Veterinary Vaccine Industry Analysis in Middle East Set to Expand with a 4% CAGR, Crossing US$973 8 Million by 2033 | FMI fmiblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fmiblog.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Life Molecular Imaging (LMI) and SOFIE Biosciences (SOFIE), a national US manufacturer and developer of PET radiopharmaceuticals, announce that.
Form 424B5 Syndax Pharmaceuticals streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The Middle East’s Veterinary Vaccine Industry is on the verge of remarkable expansion, projected to maintain a strong 4% Compound Annual Growth Rate (CAGR) until 2033. The demand outlook for veterinary vaccines in the Middle East is exceptionally positive, with an estimated market size of US$ 627.1 million in 2023.T.